Written by authors from the worldβs most prominent cancer centers, Chronic Lymphocytic Leukemia supplies a comprehensive, up-to-date picture of CLL and how to better treat patients inflicted with the disease. New information on developments in the molecular pathogenesis of this disease impacts ho
Chronic Lymphocytic Leukemia
β Scribed by P. Oppezzo
- Publisher
- Intech
- Year
- 2012
- Tongue
- English
- Leaves
- 462
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Table of Contents
00_preface_Chronic Lymphocytic Leukemia......Page 1
00x_part1......Page 15
01_Selected Topics in Chronic Lymphocytic
Leukemia Pathogenesis......Page 17
01x_part2......Page 33
02_Microenvironment Interactions in Chronic
Lymphocytic Leukemia: A Delicate Equilibrium
Linking the Quiescent and the Proliferative Pool......Page 35
03_Dysregulation of Apoptosis and
Proliferation in CLL Cells......Page 51
04_DNA Damage Response/Signaling and Genome
(In)Stability as the New Reliable Biological
Parameters Defining Clinical Feature of CLL......Page 77
05_Current Knowledge of Microarray Analysis for
Gene Expression Profiling in Chronic
Lymphocytic Leukemia......Page 109
06_Contribution of microRNAs to CLL Biology and
Their Potential as New Biomarkers......Page 133
07_The Biological Relevance of ZAP-70 in CLL......Page 149
08_Pathophysiology of Protein Kinase C Isozymes
in Chronic Lymphocytic Leukaemia......Page 167
09_The Role of Polymorphisms in Co-Signalling
Moleculesβ Genes in Susceptibility to B-Cell
Chronic Lymphocytic Leukaemia......Page 193
09x_part3......Page 215
10_Mouse Models of Chronic
Lymphocytic Leukemia......Page 217
11_Altering microRNA miR15a/16 Levels as
Potential Therapy in CLL: Extrapolating from
the De Novo NZB Mouse Model......Page 243
11x_part4......Page 263
12_Prognostic Factors in Chronic Lymphoid
Leukemia and Identification of New Clinically
Relevant Molecular Markers......Page 265
13_Genetics of Chronic Lymphocytic Leukemia:
Practical Aspects and Prognostic Significance......Page 283
13x_part5......Page 311
14_Immune Response and Immunotherapy in
Chronic Lymphocytic Leukemia......Page 313
15_In Vitro Sensitivity Testing in the Assessment of
Anti-CLL Drug Candidates......Page 337
16_Interactions of the Platinum(II) Complexes with
Nitrogen- and Sulfur-Bonding Bio-Molecules in
Chronic Lymphocytic Leukemia......Page 353
17_Infectious Diseases and Clinical Complications
During Treatment in CLL......Page 381
18_Emerging Therapies in Chronic
Lymphocytic Leukemia......Page 397
19_Heat Shock Proteins in Chronic
Lymphocytic Leukaemia......Page 413
20_Present and Future Application of Nanoparticle
Based Therapies in B-Chronic Lymphocytic
Leukemia (B-CLL)......Page 445
π SIMILAR VOLUMES
<p><P>Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. It is also the prototype of B-cell chronic lymphoid malignancies and of their ramifications within the fields of hematology, immunology and oncology. For a long time the Cinderella of lymphoid malignancies C
<p><p>This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. All aspects are considered, including pathophysiology, clinical presentation, diagnosis, prognosis, treatment, follow-up, and complications and their management. Readers
<P>Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the Western world. It is also the prototype of B-cell chronic lymphoid malignancies and of their ramifications within the fields of hematology, immunology and oncology. For aΒ long time the Cinderella of lymphoid malignancies CLL
<p>Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. CLL has a highly varied clinical course. While advances in CLL therapy are noted, many patients still succumb to this illness. Like most progress in medicine, solid advances in the diagnosis, prognosis and treatm
<p><p>This book aims to provide scientists with tools and well-researched protocols to enable their research and to facilitate further progress in this common leukemia. Written in the highly successful <i>Methods in Molecular Biology </i>series format, chapters include introductions to their respect